LUNGevity Launches New Rare Mutations and Fusions Patient Gateway

The specialized resource offers patients with rare mutations or fusions in non-small cell lung cancer (NSCLC) and their caregivers access to treatment information, informative webinars, the latest scientific news, and a supportive community.

Related Keywords

United States ,Washington ,Americans ,Amy Moore ,Astrazeneca ,Lungevity Foundation ,International Lung Cancer Survivorship Conference ,Charity Navigator ,Novartis ,Rare Mutations ,Fusions Lung Cancer Patient ,Patient Gatewaysfor ,Fusions Patient Gateway ,Patient Gateway ,Fusions Lung Cancer Patient Gateway ,Bayer Healthcare ,Clinical Trial Finder ,Lung Cancer ,Cancer ,Disease ,Non Profit ,Oncology ,Anaplastic Lymphoma Kinase ,Clinical Medicine ,Hohms ,Skras ,Neoplasms ,Non Small Cell Lung Carcinoma ,Uros1 ,Targeted Therapy ,Tyrosine Kinase Receptors ,